Brain Cancer

BRAIN CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

MRI-Based Algorithm More Predictive of Biochemical Recurrence After Prostate Cancer Surgery Than Existing Prognostic Tools

A retrospective study found that a radiomic-clinicopathologic nomogram performed better than other tools in predicting biochemical recurrence-free survival after surgery for prostate cancer.
Algorithm Proposed to Expand Cisplatin Eligibility for MIBC

A new algorithm developed by Canadian investigators aims to address underuse of cisplatin-based chemotherapy for muscle-invasive bladder cancer.
Fact Sheet: COVID-19 Vaccine Considerations for Patients With Cancer

This fact sheet reviews the current guidelines for coronavirus disease 2019 (COVID-19) vaccination in patients with cancer.
Bariatric Surgery and Colorectal Cancer: Is There a Risk?

C. Andrew Kistler, MD, PharmD, examines existing data about bariatric surgery and the risk for subsequent colorectal cancer development.
ACE2 Pathway Stimulation Enhances VEGF Inhibition in ccRCC, May Help Overcome VEGF Resistance

New study data offer insight on the mechanisms of angiotensin converting enzyme 2 (ACE2) in clear cell renal cell carcinoma (ccRCC).

BRAIN CANCER NEWS

Phase 2 studies show in vitro effectiveness in various glioblastoma multiforme cell lines.

Subset of Glioblastoma Tumors Identified as Immunotherapy Candidate

January 6, 2021

FDA_accelerated approval

Novel Treatment Gains Accelerated Approval for Relapsed/Refractory Neuroblastoma

December 1, 2020

vaccine

Autologous Dendritic Cell–Tumor Antigen Vaccine Shows Clinical Benefit in Glioblastoma

November 12, 2020

Improvements to PFS and “clinically meaningful reductions in daily corticosteroid use” were said to be linked to the addition of bevacizumab in glioblastoma.

Dexamethasone May Shorten Survival in Patients With Glioblastoma Treated With ICIs

November 12, 2020

Glioma

Role Exists for Re-Irradiation of Older Patients with Recurrent Glioma

November 10, 2020

Next post in Brain Cancer

FDA_accelerated approval

Novel Treatment Gains Accelerated Approval for Relapsed/Refractory Neuroblastoma